Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 2/2023

Open Access 13-10-2022 | Glioblastoma | Original Article

Combination of pre-treatment dynamic [18F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma

Authors: Zhicong Li, Adrien Holzgreve, Lena M. Unterrainer, Viktoria C. Ruf, Stefanie Quach, Laura M. Bartos, Bogdana Suchorska, Maximilian Niyazi, Vera Wenter, Jochen Herms, Peter Bartenstein, Joerg-Christian Tonn, Marcus Unterrainer, Nathalie L. Albert, Lena Kaiser

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 2/2023

Login to get access

Abstract

Purpose

The aim of this study was to build and evaluate a prediction model which incorporates clinical parameters and radiomic features extracted from static as well as dynamic [18F]FET PET for the survival stratification in patients with newly diagnosed IDH-wildtype glioblastoma.

Methods

A total of 141 patients with newly diagnosed IDH-wildtype glioblastoma and dynamic [18F]FET PET prior to surgical intervention were included. Patients with a survival time ≤ 12 months were classified as short-term survivors. First order, shape, and texture radiomic features were extracted from pre-treatment static (tumor-to-background ratio; TBR) and dynamic (time-to-peak; TTP) images, respectively, and randomly divided into a training (n = 99) and a testing cohort (n = 42). After feature normalization, recursive feature elimination was applied for feature selection using 5-fold cross-validation on the training cohort, and a machine learning model was constructed to compare radiomic models and combined clinical-radiomic models with selected radiomic features and clinical parameters. The area under the ROC curve (AUC), accuracy, sensitivity, specificity, and positive and negative predictive values were calculated to assess the predictive performance for identifying short-term survivors in both the training and testing cohort.

Results

A combined clinical-radiomic model comprising six clinical parameters and six selected dynamic radiomic features achieved highest predictability of short-term survival with an AUC of 0.74 (95% confidence interval, 0.60–0.88) in the independent testing cohort.

Conclusions

This study successfully built and evaluated prediction models using [18F]FET PET-based radiomic features and clinical parameters for the individualized assessment of short-term survival in patients with a newly diagnosed IDH-wildtype glioblastoma. The combination of both clinical parameters and dynamic [18F]FET PET–based radiomic features reached highest accuracy in identifying patients at risk. Although the achieved accuracy level remained moderate, our data shows that the integration of dynamic [18F]FET PET radiomic data into clinical prediction models may improve patient stratification beyond established prognostic markers.
Appendix
Available only for authorised users
Literature
10.
go back to reference Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, et al. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol. 2016;18:1199–208. https://doi.org/10.1093/neuonc/now058.CrossRef Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, et al. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol. 2016;18:1199–208. https://​doi.​org/​10.​1093/​neuonc/​now058.CrossRef
13.
15.
go back to reference Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–66. https://doi.org/10.1016/s1470-2045(09)70025-7.CrossRef Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–66. https://​doi.​org/​10.​1016/​s1470-2045(09)70025-7.CrossRef
18.
go back to reference Unterrainer M, Vettermann F, Brendel M, Holzgreve A, Lifschitz M, Zahringer M, et al. Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment? EJNMMI Res. 2017;7:48.CrossRef Unterrainer M, Vettermann F, Brendel M, Holzgreve A, Lifschitz M, Zahringer M, et al. Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment? EJNMMI Res. 2017;7:48.CrossRef
19.
go back to reference Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, et al. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0. Eur J Nucl Med Mol Imaging. 2019;46:540–57. https://doi.org/10.1007/s00259-018-4207-9.CrossRef Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, et al. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0. Eur J Nucl Med Mol Imaging. 2019;46:540–57. https://​doi.​org/​10.​1007/​s00259-018-4207-9.CrossRef
23.
24.
go back to reference Leijenaar RT, Nalbantov G, Carvalho S, van Elmpt WJ, Troost EG, Boellaard R, et al. The effect of SUV discretization in quantitative FDG-PET radiomics: the need for standardized methodology in tumor texture analysis. Sci Rep. 2015;5:11075. https://doi.org/10.1038/srep11075.CrossRef Leijenaar RT, Nalbantov G, Carvalho S, van Elmpt WJ, Troost EG, Boellaard R, et al. The effect of SUV discretization in quantitative FDG-PET radiomics: the need for standardized methodology in tumor texture analysis. Sci Rep. 2015;5:11075. https://​doi.​org/​10.​1038/​srep11075.CrossRef
25.
go back to reference Kaiser LGM, Ahmadi SA, Unterrainer M, Holzgreve A, Mille E, Gosewisch A, Brosch J, Suchorska B, Navab N, Tonn JC, Ziegler S, Bartenstein P, Albert NL, Böning G. Annual Congress of the European Association of Nuclear Medicine October 12–16, 2019 Barcelona, Spain. Eur J Nucl Med Mol Imaging. 2019;46:1–952. https://doi.org/10.1007/s00259-019-04486-2.CrossRef Kaiser LGM, Ahmadi SA, Unterrainer M, Holzgreve A, Mille E, Gosewisch A, Brosch J, Suchorska B, Navab N, Tonn JC, Ziegler S, Bartenstein P, Albert NL, Böning G. Annual Congress of the European Association of Nuclear Medicine October 12–16, 2019 Barcelona, Spain. Eur J Nucl Med Mol Imaging. 2019;46:1–952. https://​doi.​org/​10.​1007/​s00259-019-04486-2.CrossRef
27.
go back to reference Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: machine learning in Python. J Mach Learn Res. 2011;12:2825–30. Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: machine learning in Python. J Mach Learn Res. 2011;12:2825–30.
29.
go back to reference Cohen I, Huang Y, Chen J, Benesty J. Noise reduction in speech processing. Springer topics in signal processing. Springer Berlin Heidelberg; 2009. Cohen I, Huang Y, Chen J, Benesty J. Noise reduction in speech processing. Springer topics in signal processing. Springer Berlin Heidelberg; 2009.
40.
43.
go back to reference Paprottka KJ, Kleiner S, Preibisch C, Kofler F, Schmidt-Graf F, Delbridge C, et al. Fully automated analysis combining [(18)F]-FET-PET and multiparametric MRI including DSC perfusion and APTw imaging: a promising tool for objective evaluation of glioma progression. Eur J Nucl Med Mol Imaging. 2021;48:4445–55. https://doi.org/10.1007/s00259-021-05427-8.CrossRef Paprottka KJ, Kleiner S, Preibisch C, Kofler F, Schmidt-Graf F, Delbridge C, et al. Fully automated analysis combining [(18)F]-FET-PET and multiparametric MRI including DSC perfusion and APTw imaging: a promising tool for objective evaluation of glioma progression. Eur J Nucl Med Mol Imaging. 2021;48:4445–55. https://​doi.​org/​10.​1007/​s00259-021-05427-8.CrossRef
44.
47.
48.
go back to reference Lucia F, Visvikis D, Vallières M, Desseroit MC, Miranda O, Robin P, et al. External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging. 2019;46:864–77. https://doi.org/10.1007/s00259-018-4231-9.CrossRef Lucia F, Visvikis D, Vallières M, Desseroit MC, Miranda O, Robin P, et al. External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging. 2019;46:864–77. https://​doi.​org/​10.​1007/​s00259-018-4231-9.CrossRef
52.
go back to reference Reifenberger G, Weber RG, Riehmer V, Kaulich K, Willscher E, Wirth H, et al. Molecular characterization of long-term survivors of glioblastoma using genome-and transcriptome-wide profiling. Int J Cancer. 2014;135:1822–31.CrossRef Reifenberger G, Weber RG, Riehmer V, Kaulich K, Willscher E, Wirth H, et al. Molecular characterization of long-term survivors of glioblastoma using genome-and transcriptome-wide profiling. Int J Cancer. 2014;135:1822–31.CrossRef
53.
go back to reference Burgenske DM, Yang J, Decker PA, Kollmeyer TM, Kosel ML, Mladek AC, et al. Molecular profiling of long-term IDH-wildtype glioblastoma survivors. Neuro Oncol. 2019;21:1458–69.CrossRef Burgenske DM, Yang J, Decker PA, Kollmeyer TM, Kosel ML, Mladek AC, et al. Molecular profiling of long-term IDH-wildtype glioblastoma survivors. Neuro Oncol. 2019;21:1458–69.CrossRef
54.
go back to reference Park JK, Hodges T, Arko L, Shen M, Iacono DD, McNabb A, et al. Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol. 2010;28:3838.CrossRef Park JK, Hodges T, Arko L, Shen M, Iacono DD, McNabb A, et al. Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol. 2010;28:3838.CrossRef
Metadata
Title
Combination of pre-treatment dynamic [18F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma
Authors
Zhicong Li
Adrien Holzgreve
Lena M. Unterrainer
Viktoria C. Ruf
Stefanie Quach
Laura M. Bartos
Bogdana Suchorska
Maximilian Niyazi
Vera Wenter
Jochen Herms
Peter Bartenstein
Joerg-Christian Tonn
Marcus Unterrainer
Nathalie L. Albert
Lena Kaiser
Publication date
13-10-2022
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 2/2023
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-022-05988-2

Other articles of this Issue 2/2023

European Journal of Nuclear Medicine and Molecular Imaging 2/2023 Go to the issue

Obituary

In memoriam